Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
2015/09/30 by Ghodarz Akkasheh, Zahra Kashani-Poor, Maryam Ebrahimi +7 · 13 citations
Biochemistry, Genetics and Molecular Biology · Agricultural and Biological Sciences · Medicine · #Gut microbiota and health #Probiotics and Fermented Foods #Gastrointestinal motility and disorders
paper · doi:10.1016/j.nut.2015.09.003
Citations
Cited by
- Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
- Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction
- Neuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle
- Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials
- Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder
- Probiotic food consumption is associated with lower severity and prevalence of depression: A nationwide cross-sectional study
- Microbiota-Gut-Brain Axis: New Therapeutic Opportunities
- Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms
- Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial
- Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Effect of probiotics on depressive symptoms: A meta-analysis of human studies
- Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
- Nutritional Psychiatry: Where to Next?